Nautilus Biotechnology
NAUT
$2.49
Share price
5.51%
Change (1 day)
-3.49%
Change (1 year)
Categories
Nautilus Biotechnology (NAUT) - Cash on Hand
Cash on Hand as of December 2023 : $0.17 B
According to Nautilus Biotechnology's latest financial reports the company has $0.17 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nautilus Biotechnology - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | -5.99% |
| 2022-12-31 | $0.18 B | -46.64% |
| 2021-12-31 | $0.34 B | 350.51% |
| 2020-12-31 | $76.74 M |